Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer

Rafael Guerrero-Preston, Christina Michailidi, Luigi Marchionni, Curtis R. Pickering, Mitchell J. Frederick, Jeffrey N. Myers, S Yegnasubramanian, Tal Hadar, Maartje G. Noordhuis, Veronika Zizkova, Elana Fertig, Nishant Agrawal, William Westra, Wayne Martin Koch, Joseph Califano, Victor E Velculescu, David Sidransky

Research output: Contribution to journalArticle

Abstract

Tumor suppressor genes (TSGs) are commonly inactivated by somatic mutation and/or promoter methylation; yet, recent high-throughput genomic studies have not identified key TSGs inactivated by both mechanisms. We pursued an integrated molecular analysis based on methylation binding domain sequencing (MBD-seq), 450K Methylation arrays, whole exome sequencing, and whole genome gene expression arrays in primary head and neck squamous cell carcinoma (HNSCC) tumors and matched uvulopalatopharyngoplasty tissue samples (UPPPs). We uncovered 186 down-regulated genes harboring cancer specific promoter methylation including PAX1 and PAX5 and we identified 10 key tumor suppressor genes (GABRB3, HOXC12, PARP15, SLCO4C1, CDKN2A, PAX1, PIK3AP1, HOXC6, PLCB1, and ZIC4) inactivated by both promoter methylation and/or somatic mutation. Among the novel tumor suppressor genes discovered with dual mechanisms of inactivation, we found a high frequency of genomic and epigenomic alterations in the PAX gene family of transcription factors, which selectively impact canonical NOTCH and TP53 pathways to determine cell fate, cell survival, and genome maintenance. Our results highlight the importance of assessing TSGs at the genomic and epigenomic level to identify key pathways in HNSCC, deregulated by simultaneous promoter methylation and somatic mutations.

Original languageEnglish (US)
Pages (from-to)1031-1046
Number of pages16
JournalEpigenetics
Volume9
Issue number7
DOIs
StatePublished - Jan 5 2014

Fingerprint

Head and Neck Neoplasms
Tumor Suppressor Genes
Methylation
Mutation
Epigenomics
Genome
Exome
Neoplasm Genes
Cell Survival
Transcription Factors
Maintenance
Gene Expression
Genes
Neoplasms

Keywords

  • DNA methylation
  • Head and neck squamous cell carcinoma
  • Integration analysis
  • Somatic mutations
  • Tumor suppressor genes

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research

Cite this

Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer. / Guerrero-Preston, Rafael; Michailidi, Christina; Marchionni, Luigi; Pickering, Curtis R.; Frederick, Mitchell J.; Myers, Jeffrey N.; Yegnasubramanian, S; Hadar, Tal; Noordhuis, Maartje G.; Zizkova, Veronika; Fertig, Elana; Agrawal, Nishant; Westra, William; Koch, Wayne Martin; Califano, Joseph; Velculescu, Victor E; Sidransky, David.

In: Epigenetics, Vol. 9, No. 7, 05.01.2014, p. 1031-1046.

Research output: Contribution to journalArticle

Guerrero-Preston, R, Michailidi, C, Marchionni, L, Pickering, CR, Frederick, MJ, Myers, JN, Yegnasubramanian, S, Hadar, T, Noordhuis, MG, Zizkova, V, Fertig, E, Agrawal, N, Westra, W, Koch, WM, Califano, J, Velculescu, VE & Sidransky, D 2014, 'Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer', Epigenetics, vol. 9, no. 7, pp. 1031-1046. https://doi.org/10.4161/epi.29025
Guerrero-Preston, Rafael ; Michailidi, Christina ; Marchionni, Luigi ; Pickering, Curtis R. ; Frederick, Mitchell J. ; Myers, Jeffrey N. ; Yegnasubramanian, S ; Hadar, Tal ; Noordhuis, Maartje G. ; Zizkova, Veronika ; Fertig, Elana ; Agrawal, Nishant ; Westra, William ; Koch, Wayne Martin ; Califano, Joseph ; Velculescu, Victor E ; Sidransky, David. / Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer. In: Epigenetics. 2014 ; Vol. 9, No. 7. pp. 1031-1046.
@article{e09e2f7b04174050a17d9488bf11682d,
title = "Key tumor suppressor genes inactivated by {"}greater promoter{"} methylation and somatic mutations in head and neck cancer",
abstract = "Tumor suppressor genes (TSGs) are commonly inactivated by somatic mutation and/or promoter methylation; yet, recent high-throughput genomic studies have not identified key TSGs inactivated by both mechanisms. We pursued an integrated molecular analysis based on methylation binding domain sequencing (MBD-seq), 450K Methylation arrays, whole exome sequencing, and whole genome gene expression arrays in primary head and neck squamous cell carcinoma (HNSCC) tumors and matched uvulopalatopharyngoplasty tissue samples (UPPPs). We uncovered 186 down-regulated genes harboring cancer specific promoter methylation including PAX1 and PAX5 and we identified 10 key tumor suppressor genes (GABRB3, HOXC12, PARP15, SLCO4C1, CDKN2A, PAX1, PIK3AP1, HOXC6, PLCB1, and ZIC4) inactivated by both promoter methylation and/or somatic mutation. Among the novel tumor suppressor genes discovered with dual mechanisms of inactivation, we found a high frequency of genomic and epigenomic alterations in the PAX gene family of transcription factors, which selectively impact canonical NOTCH and TP53 pathways to determine cell fate, cell survival, and genome maintenance. Our results highlight the importance of assessing TSGs at the genomic and epigenomic level to identify key pathways in HNSCC, deregulated by simultaneous promoter methylation and somatic mutations.",
keywords = "DNA methylation, Head and neck squamous cell carcinoma, Integration analysis, Somatic mutations, Tumor suppressor genes",
author = "Rafael Guerrero-Preston and Christina Michailidi and Luigi Marchionni and Pickering, {Curtis R.} and Frederick, {Mitchell J.} and Myers, {Jeffrey N.} and S Yegnasubramanian and Tal Hadar and Noordhuis, {Maartje G.} and Veronika Zizkova and Elana Fertig and Nishant Agrawal and William Westra and Koch, {Wayne Martin} and Joseph Califano and Velculescu, {Victor E} and David Sidransky",
year = "2014",
month = "1",
day = "5",
doi = "10.4161/epi.29025",
language = "English (US)",
volume = "9",
pages = "1031--1046",
journal = "Epigenetics",
issn = "1559-2294",
publisher = "Landes Bioscience",
number = "7",

}

TY - JOUR

T1 - Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer

AU - Guerrero-Preston, Rafael

AU - Michailidi, Christina

AU - Marchionni, Luigi

AU - Pickering, Curtis R.

AU - Frederick, Mitchell J.

AU - Myers, Jeffrey N.

AU - Yegnasubramanian, S

AU - Hadar, Tal

AU - Noordhuis, Maartje G.

AU - Zizkova, Veronika

AU - Fertig, Elana

AU - Agrawal, Nishant

AU - Westra, William

AU - Koch, Wayne Martin

AU - Califano, Joseph

AU - Velculescu, Victor E

AU - Sidransky, David

PY - 2014/1/5

Y1 - 2014/1/5

N2 - Tumor suppressor genes (TSGs) are commonly inactivated by somatic mutation and/or promoter methylation; yet, recent high-throughput genomic studies have not identified key TSGs inactivated by both mechanisms. We pursued an integrated molecular analysis based on methylation binding domain sequencing (MBD-seq), 450K Methylation arrays, whole exome sequencing, and whole genome gene expression arrays in primary head and neck squamous cell carcinoma (HNSCC) tumors and matched uvulopalatopharyngoplasty tissue samples (UPPPs). We uncovered 186 down-regulated genes harboring cancer specific promoter methylation including PAX1 and PAX5 and we identified 10 key tumor suppressor genes (GABRB3, HOXC12, PARP15, SLCO4C1, CDKN2A, PAX1, PIK3AP1, HOXC6, PLCB1, and ZIC4) inactivated by both promoter methylation and/or somatic mutation. Among the novel tumor suppressor genes discovered with dual mechanisms of inactivation, we found a high frequency of genomic and epigenomic alterations in the PAX gene family of transcription factors, which selectively impact canonical NOTCH and TP53 pathways to determine cell fate, cell survival, and genome maintenance. Our results highlight the importance of assessing TSGs at the genomic and epigenomic level to identify key pathways in HNSCC, deregulated by simultaneous promoter methylation and somatic mutations.

AB - Tumor suppressor genes (TSGs) are commonly inactivated by somatic mutation and/or promoter methylation; yet, recent high-throughput genomic studies have not identified key TSGs inactivated by both mechanisms. We pursued an integrated molecular analysis based on methylation binding domain sequencing (MBD-seq), 450K Methylation arrays, whole exome sequencing, and whole genome gene expression arrays in primary head and neck squamous cell carcinoma (HNSCC) tumors and matched uvulopalatopharyngoplasty tissue samples (UPPPs). We uncovered 186 down-regulated genes harboring cancer specific promoter methylation including PAX1 and PAX5 and we identified 10 key tumor suppressor genes (GABRB3, HOXC12, PARP15, SLCO4C1, CDKN2A, PAX1, PIK3AP1, HOXC6, PLCB1, and ZIC4) inactivated by both promoter methylation and/or somatic mutation. Among the novel tumor suppressor genes discovered with dual mechanisms of inactivation, we found a high frequency of genomic and epigenomic alterations in the PAX gene family of transcription factors, which selectively impact canonical NOTCH and TP53 pathways to determine cell fate, cell survival, and genome maintenance. Our results highlight the importance of assessing TSGs at the genomic and epigenomic level to identify key pathways in HNSCC, deregulated by simultaneous promoter methylation and somatic mutations.

KW - DNA methylation

KW - Head and neck squamous cell carcinoma

KW - Integration analysis

KW - Somatic mutations

KW - Tumor suppressor genes

UR - http://www.scopus.com/inward/record.url?scp=84902599616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902599616&partnerID=8YFLogxK

U2 - 10.4161/epi.29025

DO - 10.4161/epi.29025

M3 - Article

C2 - 24786473

AN - SCOPUS:84902599616

VL - 9

SP - 1031

EP - 1046

JO - Epigenetics

JF - Epigenetics

SN - 1559-2294

IS - 7

ER -